WuXi Advanced Therapies’ Philadelphia Site Approved by FDA to Start Manufacturing Iovance’s Melanoma T-cell Therapy

1 min read

Amtagvi is the first one-time, individualized T-cell therapy approved by the FDA for any solid tumor cancer.

You May Also Like

More From Author

+ There are no comments

Add yours